Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design

Drug Development and Industrial Pharmacy

Volumn 34, Issue 8, 2008, Pages 903-910

  Genc, Lutfi ^a   Jalvand, Esmaeil ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Cellulose derivatives; Controlled release; Factorial design; Hydrophilic matrix tablet; Ketorolac tromethamine

Indexed keywords

CARBOXYMETHYLCELLULOSE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL;

ACCURACY; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DETERMINATION; DRUG SOLUBILITY; FACTORIAL DESIGN; HYDROPHILICITY; IN VITRO STUDY; QUALITY CONTROL; REPRODUCIBILITY; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MATRIX; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION STUDY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBOXYMETHYLCELLULOSE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; KETOROLAC TROMETHAMINE; METHYLCELLULOSE; TABLETS;

EID: 49449110586     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802266170     Document Type: Article

References (24)

1. Aǧabeyoǧlu, T. İ. (1984). Dissol; A basic computer program for the kinetic assesment of dissolution data. İstanbul: Presented at National Pharmaceutical Congress.
2. Baveja, S. K., Ranga-Rao, K. V., & Padmalatha Devi, K. (1987). Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int. J. Pharm., 39, 39-45.
3. Bettini, R., Colombo, P., Massimo, G., Catellani, P. L., & Vitali, T. (1994). Swelling and drug release in hydrogel matrices; polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci., 2, 213-219.
4. Beuving, G. (2001). Validation of Analytical Methods, Validation Seminar, 31 May-01 June, İstanbul.
5. Bravo, S. A., Lamas, M. C., & Salomon, C. J. (2002). In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J. Pharm. Pharm. Sci., 5(3), 213-219.
6. Buckley, M. M.-T., & Brogden, R. N. (1990). Ketorolac, A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs, 39(1), 86-109.
7. Caporal-Gautier, J., Nivet, J. M., Algranti, P., Guilloteau, M., Histe, M., Lallier, M., N'guyen-Huu, J. J., & Russotto, R. (1992). Guide de validation analytique rapport d'une commission SFSTP I. Methodology. STP. Pharma Prat., 2(4), 205-226.
8. Çelebi, N., & Ünlü, G. (1999). Formulation and evaluation of hydrophilic matrix tablets of diltiazem using factorial design based studies. Pharmazie, 54(12), 910-914.
9. Colombo, P., Bettini, R., & Peppas, N. A. (1999). Observation of swelling process and diffusion front position during swelling in HPMC matrices containing a soluble drug. J. Control. Release, 61(1-2), 83-91.
10. Ford, J. L., Rubinstein, M. H., Mclaul, F., Hogan, J. E., & Edgarp, J. (1987). Importance of drug type, tablet shape and added diluents on drug release kinetics from HPMC matrix tablets. Int. J. Pharm., 40, 223-234.
11. Kibbe, A. H. (Ed.). (2000). Handbook of pharmaceutical excipients (3rd ed., pp. 84-256). American Pharmaceutical Association (APhA) Washington, DC: Pharmaceutical Press (PhP).
12. Hashim, A., & Wan Po, L. A. (1987). Improving the release characteristics of water-soluble drugs from hydrophilic sustained release matrices by in situ gas generation. Int. J. Pharm., 35, 201-209.
13. Heng, P. W. S., Chan, L. W., Easterbrook, M. G., & Li, X. (2001). Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J. Control. Release, 76(1-2), 39-49.
14. Higuchi, T. (1963). Mechanism of sustained-action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52(12), 1145-1149.
15. Juárez, H., Rico, G., & Villafuerte, L. (2001). Influence of admixed CMC on release of 4-amino-pyridine from HPMC matrix tablets. Int. J. Pharm., 216(1-2), 115-125.
16. Kamath, B. V., Shivram, K., & Vangani, S. (1994). Spectrophotometric determination of Ketorolac tromethamine by charge transfer and ion-pair complexation. Anal. Lett., 27(1), 103-112.
17. Montgomery, D. C. (Ed.). (1997). Design and analysis of experiments (Chapter 7, p. 290). New York: Copyright, by John & Sons, Inc.
18. Mroszczak, E. J., Lee, F. W., Combs, D., Sarnquist, F. H., Huang, B.-L., Wu, A. T., Tokes, L. G., Maddox, M. L., & Cho, D. K. (1987). Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans. Drug Metab. Dispos., 15(5), 618-626.
19. Riley, C. M., & Rosanske, T. W. (Eds.). (1996). Development and validation of analytical methods. Progress in pharmaceutical and biomedical analysis (1st ed., Vol. 3, pp. 20-22). New York, NY: Elsevier Science Inc.
20. Reynolds, T. D., Mitchell, S. A., & Balwinski, K. M. (2002). Investigation of the effect of tablet surface area/volume on drug release from HPMC controlled-release matrix tablets. Drug Dev. Ind. Pharm., 28(4), 457-466.
21. Tiwari, S. B., Murthy, T. K., Pai, M. R., Mehta, P. R., & Chowdary, P. B. (2003). Controlled release formulations of Tramadol HCl using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Tech., 4(3), 1-6.
22. The United States Pharmacopeia (USP 24), The National Formulary (NF 19) (2000). Rockville, MD: United States Pharmacopeial Convention, Inc.
23. Vázquez, M.-V., Casalderry, M., Duro, R., Gómez-Amoza, J.-L., Martínez-Pacheco, R., Souto, C., & Concheiro, A. (1996). Atenolol release from hydrophilic matrix tablets with HPMC mixtures as gelling agent: Effects of the HPMC mixture. Eur. J. Pharm. Sci., 4, 9-48.
24. Vazquez, M. J., Perez-Marcos, B., Gomez-Amoza, J. L., Martinez-Pacheco, R., Souto, C., & Concheiro, A. (1992). Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev. Ind. Pharm., 18(11-12), 1355-1375.